✦ LIBER ✦

Pharmacologic and Pharmacokinetic Profile of Class III Antiarrhythmic Drugs

✍ Scribed by Peter R Kowey MD; Roger A Marinchak MD; Seth J Rials MD; PhD; David Bharucha MD; PhD

Book ID: 113978821
Publisher: Elsevier Science
Year: 1997
Tongue: English
Weight: 114 KB
Volume: 80
Category: Article
ISSN: 0002-9149
DOI: 10.1016/s0002-9149(97)00710-8

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

MS-551: Pharmacological profile of a nov

MS-551: Pharmacological profile of a novel class III antiarrhythmic agent

✍ Joji Kamiya; Masaaki Ishii; Kanji Yoshihara; Akihiro Oyabe; Hitoshi Banno; Tstut 📂 Article 📅 1993 🏛 John Wiley and Sons 🌐 English ⚖ 645 KB

Risk and Benefit Class III Antiarrhythmi

Risk and Benefit Class III Antiarrhythmic Drugs

📂 Article 📅 1993 🏛 John Wiley and Sons 🌐 English ⚖ 189 KB

Rate-dependence of antiarrhythmic and pr

Rate-dependence of antiarrhythmic and proarrhythmic properties of class I and class III antiarrhythmic drugs

✍ J. Weirich; H. Antoni 📂 Article 📅 1998 🏛 Springer 🌐 English ⚖ 191 KB

Potentially Significant Drug Interaction

Potentially Significant Drug Interactions of Class III Antiarrhythmic Drugs

✍ Dr Weeranuj Yamreudeewong, Michael DeBisschop, Linda G. Martin, Dennis L. Lower 📂 Article 📅 2003 🏛 Springer International Publishing AG 🌐 English ⚖ 147 KB

The Side Effect Profile of Class III Ant

The Side Effect Profile of Class III Antiarrhythmic Drugs: Focus on d,l-Sotalol

✍ Daniel J. MacNeil MD 📂 Article 📅 1997 🏛 Elsevier Science 🌐 English ⚖ 128 KB

Pharmacokinetic and pharmacodynamic effe

Pharmacokinetic and pharmacodynamic effects of UK-68,798, a new potential class III antiarrhythmic drug.

✍ M. Sedgwick; HS Rasmussen; D. Walker; SM Cobbe 📂 Article 📅 1991 🏛 John Wiley and Sons 🌐 English ⚖ 887 KB